Change in criteria for USP dissolution performance verification tests

Walter W. Hauck, Anthony J. DeStefano, William E. Brown, Erika S. Stippler, Darrell R. Abernethy, William F. Koch, Roger L. Williams

Research output: Contribution to journalArticle

Abstract

The US Pharmacopeial Convention has been evaluating its performance verification tests (PVT) for several years. These tests help ensure the integrity of the US Pharmacopeia performance test when a dissolution procedure, as described in General Chapter Dissolution <711>, is relied upon to test a nonsolution orally administered dosage form. One result of the evaluation is a change in the PVT criterion from one based on individual tablet results to one based on the mean and variability of a set of tablets. This paper describes the new PVT and its criterion and how its acceptance limits are derived from results of a collaborative study, explains a two-stage option for the test, and presents operating characteristics.

Original languageEnglish (US)
Pages (from-to)21-26
Number of pages6
JournalAAPS PharmSciTech
Volume10
Issue number1
DOIs
StatePublished - Jan 12 2009

Keywords

  • Acceptance criteria
  • Data analysis
  • Dissolution test
  • Performance verification test
  • Reference standards

ASJC Scopus subject areas

  • Pharmaceutical Science

Fingerprint Dive into the research topics of 'Change in criteria for USP dissolution performance verification tests'. Together they form a unique fingerprint.

  • Cite this

    Hauck, W. W., DeStefano, A. J., Brown, W. E., Stippler, E. S., Abernethy, D. R., Koch, W. F., & Williams, R. L. (2009). Change in criteria for USP dissolution performance verification tests. AAPS PharmSciTech, 10(1), 21-26. https://doi.org/10.1208/s12249-008-9169-y